The difference in the association between BRCA1 and BRCA2 carriers may be explained by the difference in proportions of estrogen receptor (ER)-positive breast cancer (22% for BRCA1, 77% for BRCA2) [27]. This evidence concerns the gene BRCA1 and breast cancer.